Expanding Access: Low-Barrier, Hepatitis C Treatment in Addiction Clinics

Sunday, April 26, 2026

10:15 AM - 11:30 AM PT

Location: America's Cup, Level 4

Presenter(s)

MT

Marissa Tan, DO, MPH, MAS

Attending physician
Cooper
Camden, New Jersey

Slides Handouts
XG

Xin Gao, PharmD, MSc

Clinical Pharmacist
Cooper University Healthcare
Camden, New Jersey
Rachel Ehrman-Dupre, MD

Attending Physician
Cooper University Healthcare
Philadelphia, Pennsylvania

Slides Handouts

This workshop is ideal for addiction medicine providers, clinic managers, and care team members interested in reducing barriers to HCV care and improving health equity. No prior HCV treatment experience is required. This session will harness participants’ varied experiences to facilitate a robust brainstorming session; Participants will walk away with actionable next steps tailored to their clinical setting, regardless of whether it's in the early stages of HCV screening or advanced stages of developing innovative new treatment delivery models.

Learning Objectives:

Learners will be able to:

Learn to screen, diagnose, treat, and monitor hepatitis C treatment within office-based addiction clinics.
Learn how to use a hepatitis C cascade of care to identify system barriers to treatment.
Learn how to navigate regulatory, systemic, and psychosocial barriers to care.

Disclosure(s):

Marissa Tan, DO, MPH, MAS: No financial relationships to disclose

Xin Gao, PharmD, MSc: No financial relationships to disclose

Rachel Ehrman-Dupre, MD: No financial relationships to disclose